Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44.8M
-
Number of holders
-
406
-
Total 13F shares, excl. options
-
43.4M
-
Shares change
-
+858K
-
Total reported value, excl. options
-
$7.78B
-
Value change
-
+$131M
-
Put/Call ratio
-
0.73
-
Number of buys
-
192
-
Number of sells
-
-196
-
Price
-
$179.41
Significant Holders of UNITED THERAPEUTICS Corp - Common Stock (UTHR) as of Q1 2022
482 filings reported holding UTHR - UNITED THERAPEUTICS Corp - Common Stock as of Q1 2022.
UNITED THERAPEUTICS Corp - Common Stock (UTHR) has 406 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 43.4M shares
of 44.8M outstanding shares and own 96.85% of the company stock.
Largest 10 shareholders include BlackRock Inc. (4.28M shares), VANGUARD GROUP INC (4.17M shares), Avoro Capital Advisors LLC (3.03M shares), RENAISSANCE TECHNOLOGIES LLC (2.77M shares), FMR LLC (2.71M shares), WELLINGTON MANAGEMENT GROUP LLP (1.68M shares), STATE STREET CORP (1.63M shares), Bank of New York Mellon Corp (832K shares), Avidity Partners Management LP (719K shares), and FULLER & THALER ASSET MANAGEMENT, INC. (664K shares).
This table shows the top 406 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.